ReebaMathewWeb Sleep expert offers tips to get children back on a school sleep schedule

To get your young scholar off to a good start this school year, it’s important to make sure he or she is well-rested when the bell sounds, according to Reeba Mathew, M.D., a sleep expert with McGovern Medical School.


Rios addresses United Nations on HIV vaccine research

Dr. Adan Rios, associate professor of internal medicine, made a pair of special appearances on the world stage again last month to discuss the challenges with the development of a preventative HIV vaccine.


KoenigResearch Rapamycin lotion reduces facial tumors caused by tuberous sclerosis, UTHealth reports

Addressing a critical issue for people with a genetic disorder called tuberous sclerosis complex (TSC), doctors at McGovern Medical School reported that a skin cream containing rapamycin significantly reduced the disfiguring facial tumors affecting more than 90 percent of people with the condition.


Researcher reveals results of study on emergency breathing tubes

In a landmark study, researchers found that patients treated with paramedic oxygen delivery using a newer, more flexible laryngeal breathing tube may have a greater survival rate after sudden cardiac arrest than the traditional intubation breathing tube.


NorrisEdmondsonResearch Microbiologists make breakthrough in syphilis research

A scientific quest that started in 1905 has been achieved by scientists at McGovern Medical School, who reported that they are the first to grow a long-lasting tissue culture of the bacterium responsible for syphilis. Findings appeared in the journal mBio.


tinytotteam Tiny Tot Clinic secures grant for cerebral palsy research

The Tiny Tot Clinic for Neurodevelopmental and Behavioral Health at UT Physicians, the clinical practice of McGovern Medical School, is now one of only seven programs nationwide to be invited to take part in a new initiative by the Cerebral Palsy Foundation designed to improve diagnosis and intervention results.


SoyLecithinStory Study: Soy lecithin NSAID combo drug protects against cancer with fewer side effects

When scientists at McGovern Medical School applied a chemical found in soybeans to a non-steroidal anti-inflammatory drug (NSAID), they increased its anticancer properties and reduced its side effects. Findings of the preclinical study of phosphatidylcholine, also called lecithin, appear in the journal Oncology Letters.


Dr. Balveen Kaur Size matters when fighting cancer, groundbreaking UTHealth study finds

Doctors could be a step closer to finding the most effective way to treat cancer with a double whammy of a virus combined with boosting the natural immune system, according to a pioneering study by researchers at The University of Texas Health Science Center at Houston (UTHealth) and The Ohio State University.


Dr. Amrou Sarraj Study: Simpler scan still effective in deciding stroke treatment

A study led by a neurologist from McGovern Medical School showed that a computed tomography (CT scan) could be sufficient for determining thrombectomy treatment in stroke.


Dr. Ruth Heidelberger McGovern Medical School professors showcase research at Biophysical Society Annual Meeting

Professors from several departments at McGovern Medical School shared research presentations with thousands of scientists in biophysics at the 62nd Annual Meeting of the Biophysical Society (BPS) earlier this year.